Effects of tumor suppressor gene NGX6 on growth of human colon cancer cell line HT-29

World Chinese Journal of Digestology

Volumn 12, Issue 3, 2004, Pages 574-579

  Wang, Moo Yan ^a   Shen, Shou Rong ^a   Liu, Hua Ying ^b   Zhang, Xiao Mei ^a   Peng, Cong ^b   Huang, He ^b   Li, Fen ^a   Li, Xiao Ling ^b   Li, Gui Yuan ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; LIPOSOME;

ARTICLE; CANCER CYTODIAGNOSIS; CARCINOGENESIS; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL STRAIN; CLONOGENESIS; COLON CANCER; COLON CARCINOGENESIS; CONTROLLED STUDY; DIAGNOSTIC TEST; DOT HYBRIDIZATION; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; NGX6 GENE; NUDE MOUSE; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOFT AGAR ASSAY; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE; XENOGRAFT;

EID: 2442593546     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Cheng L, Lai MD. Aberrant crypt foci as microscopic precursors of colorectal cancer. WorId J Gastroenterol 2003;9:2642-2649
2. Ji CY, Smith DR, Goh HS. Prognostic significance of p53 overexpression and mutation in colorectal adeno carcinomas. Br J Cancer 1996;74:216-223
3. Fang JY, Lu J, Chen YX, Yang L. Effects of DNA methylation on expression of tumor suppressor genes and proto-oncogene in human colon cancer cell lines. World J Gastroenterol 2003,9: 1976-1980
4. Yan W, Wang WL, Zhu F, Chen SQ, Li QL, Wang L. Isolation of a novel member of small G protein suprefamily and its expression in colon cancer. World J Gastroenterol 2003;9:1719-1724
5. Cai KL, Wang GB, Xiong LJ.Effects of carbon dioxide and nitrogen on adhesive growth and expression of E-cadherin and VEGF of human colon cancer cell CCL-228. World J Gastroenterol 2003;9:1594-1597
6. Zhu JW, Yu BM, Ji YB, Zheng MH, Li DH. Upregulation of vascular endothelial growth factor by hydrogen peroxide in human colon cancer. World J Gastroenterol 2002;8:153-157
7. Clarke LE, Leitzel K, Smith J, Ali SM, Lipton A. Epidermal growth factor receptor mRNA in peripheral blood of patients with pancreatic, lung, and colon carcinomas detected by RT-PCR. Int J Oncol 2003;22:425-430
8. Khorana AA, Ryan CK, Cox C, Eberly S, Sahasrabudhe DM. Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with Stage II and Stage III colon carcinoma: a role for the host response in prognosis. Cancer 2003;97:960-968
9. Goldstein NS, Armin M. Epidermal growth factor receptor immunohistochemical reactivity in patients with American joint committee on cancer stage IV colon adenocarcinoma: implications for a standardized scoring system. Cancer 2001; 92:1331-1346
10. Gainet M, Guardiola E, Dufresne A, Pivot X. Epidermal growth factor receptors (EGFR): a new target for anticancer therapy. Cancer Radiother 2003;7:195-199
11. Xiong W, Zeng ZY, Li XL. Single-nucleotide polymorphisms in NGX6 gene and their correlation with nasopharyngeal carcinoma. Shengwu Huaxue Yu Shengwu Wuli Xuebao 2002; 34:512-515
12. Watanabe N. Oncogene and tumor suppressor gene. Rinsho Byori 2002;123(Suppl):131-136
13. Zajac V, Tomka M, Ilencikova D, Majek P, Stevurkova V, Kirchhoff T. A double germline mutations in the APC and p53 genes. Neoplasma 2000;47:335-341
14. Vecsey-Semjen B, Becker KF, Sinski A, Blennow E, Vietor I, Zatloukal K, Beug H, Wagner E, Huber LA. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers. Oncogene 2002;21:4646-4662
15. Takahashi Y, Ellis LM, Wilson MR, Bucana CD, Kitadai Y, Fidler IJ. Progressive upregulation of metastasis-related genes in human colon cancer cells implanted into the cecum of nude mice. Oncol Res 1996;8:163-169
16. Mendelsohn J. The epidermal growth factor receptor as a target for cancer therapy. Endocr Relat Cancer 2001;8:3-9
17. Radinsky R, Risin, Fan, Dong, Bielenberg, Bucana, Fidler. Level and function of epidermal growth factor receptor predict the metastatic potential of human colon carcinoma cells. Clin Cancer Res 1995;1:19-31
18. De Jong KP, Stellema R, Karrenbeld A, Koudstaal J, Gouw AS, Sluiter WJ, Peeters PM, Slooff MJ, De Vries EG. Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors. Hepatology 1998;28:971-979
19. Parker C, Roseman BJ, Bucana CD, Tsan R, Radinsky R. Preferential activation of the epidermal growth factor receptor in human colon carcinoma liver metastases in nude mice. J Histochem Cytochem 1998;46:595-602
20. Williams SJ, McGuckin MA, Gotley DC, Eyre HJ, Sutherland GR, Antalis TM. Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res 1999;59:4083-4089
21. Zhang XM, Wang XY, Sheng SR, Wang JR, Li J. Expression of tumor related genes NGX6, NAG 7 BRD7 in gastric cancer and colonorectal cancer. World J Gastroenterol 2003;9:1729-1733
22. Bartkova J, Rajpert-De Meyts E, Skakkebaek NE, Lukas J, Bartek J. Deregulation of the G1/S-phase control in human testicular germ cell tumours. APMIS 2003;111:252-265
23. Blagosklonny MV, Pardee AB. The restriction point of the cell cycle. Cell Cycle 2002;1:103-110
24. Michalides RJ, van de Brekel M, Balm F. Defects in G1-S cell cycle control in head and neck cancer: a review. Head Neck 2002;24:694-704
25. Malumbres M, Barbacid M. To cycle or not to cycle: a critical decision in cancer. Nat Rev Cancer 2001;1:222-231